We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-18.84%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$189M
AUM Growth
-$35.6M
Cap. Flow
+$958K
Cap. Flow %
0.51%
Top 10 Hldgs %
53.49%
Holding
84
New
11
Increased
22
Reduced
15
Closed
36

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$9.77M
2
IIN
IntriCon Corporation
IIN
+$8.08M
3
AGN
Allergan plc
AGN
+$6.65M
4
EHC icon
Encompass Health
EHC
+$6.1M
5
MDRX
Veradigm Inc. Common Stock
MDRX
+$5.74M

Top Sells

Rank Stock Value
1
TVTY
Tivity Health, Inc. Common Stock
TVTY
+$9.99M
2
SHPG
Shire pic
SHPG
+$7.7M
3
ABT icon
Abbott
ABT
+$5.78M
4
MRK icon
Merck
MRK
+$5.68M
5
BAX icon
Baxter International
BAX
+$5.26M

Sector Composition

Rank Sector Weight
1 Healthcare 91.46%
2 Industrials 3.75%
3 Technology 3.46%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
26
Viatris
VTRS
$20.4B
$2.11M 1.12%
77,135
-30,643
-28% -$993K
LAB icon
27
Standard BioTools
LAB
$340M
$2.04M 1.08%
236,648
-325,936
-58% -$2.54M
RVLP
28
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$1.8M 0.95%
+232,048
New +$1.86M
PETS icon
29
PetMed Express
PETS
$41.7M
$1.56M 0.82%
+67,010
New +$1.79M
ARAY icon
30
Accuray
ARAY
$32M
$1.55M 0.82%
+455,018
New +$1.85M
ARRY
31
DELISTED
Array Biopharma Inc
ARRY
$1.46M 0.77%
102,345
-10,355
-9% -$157K
IRTC icon
32
iRhythm Holdings
IRTC
$3.85B
$1.25M 0.66%
+18,018
New +$1.37M
SYK icon
33
Stryker
SYK
$125B
$1.15M 0.61%
7,319
-19,502
-73% -$3.26M
TEVA icon
34
Teva Pharmaceuticals
TEVA
$40.8B
$1.14M 0.6%
+73,884
New +$1.51M
BSX icon
35
Boston Scientific
BSX
$69.5B
$1.08M 0.57%
30,560
-39,847
-57% -$1.45M
OCUL icon
36
Ocular Therapeutix
OCUL
$1.79B
$926K 0.49%
232,727
-69,426
-23% -$383K
JNJ icon
37
Johnson & Johnson
JNJ
$618B
$850K 0.45%
6,588
+4,119
+167% +$575K
LQDA icon
38
Liquidia Corp
LQDA
$7.48B
$848K 0.45%
39,139
+15,054
+63% +$352K
AXGN icon
39
Axogen
AXGN
$2.27B
$816K 0.43%
39,961
+10,887
+37% +$341K
ANAB icon
40
AnaptysBio
ANAB
$1.58B
$812K 0.43%
+12,734
New +$947K
COR icon
41
Cencora
COR
$60.6B
$620K 0.33%
+8,340
New +$719K
AXSM icon
42
Axsome Therapeutics
AXSM
$11.2B
$590K 0.31%
209,195
+114,010
+120% +$375K
FOLD
43
DELISTED
Amicus Therapeutics
FOLD
$558K 0.29%
58,240
-12,528
-18% -$138K
ALDX icon
44
Aldeyra Therapeutics
ALDX
$92.9M
$553K 0.29%
66,639
-3,361
-5% -$34.4K
MCK icon
45
McKesson
MCK
$100B
$549K 0.29%
4,966
+2,144
+76% +$267K
VKTX icon
46
Viking Therapeutics
VKTX
$3.7B
$409K 0.22%
53,466
-18,511
-26% -$221K
KRYS icon
47
Krystal Biotech
KRYS
$10.1B
$260K 0.14%
+12,500
New +$262K
A icon
48
Agilent Technologies
A
$39.1B
– –
-17,286
Closed -$1.22M
ABT icon
49
Abbott
ABT
$183B
– –
-78,718
Closed -$5.78M
ACAD icon
50
Acadia Pharmaceuticals
ACAD
$4.43B
– –
-32,371
Closed -$672K
1
2
3 4

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Endurant Capital Management held 84 positions worth $189M, down 16% from $225M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Endurant Capital Management's Q4 2018 filing shows 11 new, 22 increased, 15 reduced and 36 closed positions. Its largest new stake was Encompass Health: 107,187 shares worth $5.26M. The largest sale was Tivity Health, Inc. Common Stock, an estimated $9.99M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 93% a quarter earlier, followed by Industrials and Technology.

  • Endurant Capital Management's largest Q4 2018 buy was Encompass Health: 107,187 shares worth $5.26M.
  • Endurant Capital Management added most to Zimmer Biomet in Q4 2018, an estimated $9.77M increase.
  • Endurant Capital Management's biggest Q4 2018 reduction was Shire pic, cutting an estimated $7.7M.
  • Endurant Capital Management fully exited Tivity Health, Inc. Common Stock in Q4 2018, selling an estimated $9.99M.
  • Endurant Capital Management's ten largest holdings make up 53% of its $189M portfolio in Q4 2018.
  • Endurant Capital Management opened 11 new positions and closed 36 in Q4 2018.
  • Endurant Capital Management's portfolio value fell 16% quarter-over-quarter to $189M.

Based on Endurant Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.